Cargando…

Opioids and Breast Cancer Recurrence: A Systematic Review

SIMPLE SUMMARY: Opioids are one of the therapeutic and palliative options for breast cancer, a tumor with a strong epidemiological impact. Studies have been extensively reported in the literature that show a connection between the administration of opioids and the recurrence of the disease, both dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Lucia, Merlino, Luca, Titi, Federica, Del Prete, Cecilia, Galli, Chiara, Mandosi, Laura, De Marchis, Carlo, Della Rocca, Grazia, Piccioni Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583615/
https://www.ncbi.nlm.nih.gov/pubmed/34771662
http://dx.doi.org/10.3390/cancers13215499
_version_ 1784597246405246976
author Lucia, Merlino
Luca, Titi
Federica, Del Prete
Cecilia, Galli
Chiara, Mandosi
Laura, De Marchis
Carlo, Della Rocca
Grazia, Piccioni Maria
author_facet Lucia, Merlino
Luca, Titi
Federica, Del Prete
Cecilia, Galli
Chiara, Mandosi
Laura, De Marchis
Carlo, Della Rocca
Grazia, Piccioni Maria
author_sort Lucia, Merlino
collection PubMed
description SIMPLE SUMMARY: Opioids are one of the therapeutic and palliative options for breast cancer, a tumor with a strong epidemiological impact. Studies have been extensively reported in the literature that show a connection between the administration of opioids and the recurrence of the disease, both during surgery and subsequently in the management of cancer pain. This argument, in consideration of the strong impact of this cancer, is of great interest. Therefore, we decided, through the study of the existing literature, to describe the state of the art on this topic, to outline the best therapeutic approach to be adopted in these delicate patients. ABSTRACT: Breast cancer has the greatest epidemiological impact in women. Opioids represent the most prescribed analgesics, both in surgical time and in immediate postoperative period, as well as in chronic pain management as palliative care. We made a systematic review analyzing the literature’s evidence about the safety of opioids in breast cancer treatment, focusing our attention on the link between opioid administration and increased relapses. The research has been conducted using the PubMed database. Preclinical studies, retrospective and prospective clinical studies, review articles and original articles were analyzed. In the literature, there are several preclinical in vitro and in vivo studies, suggesting a possible linkage between opioids administration and progression of cancer disease. Nevertheless, these results are not confirmed by clinical studies. The most recent evidence reassures the safety of opioids during surgical time as analgesic associated with anesthetics drugs, during postoperative period for optimal cancer-related pain management and in chronic use. Currently, there is controversial evidence suggesting a possible impact of opioids on breast cancer progression, but to date, it remains an unresolved issue. Although there is no conclusive evidence, we hope to arouse interest in the scientific community to always ensure the best standards of care for these patients.
format Online
Article
Text
id pubmed-8583615
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85836152021-11-12 Opioids and Breast Cancer Recurrence: A Systematic Review Lucia, Merlino Luca, Titi Federica, Del Prete Cecilia, Galli Chiara, Mandosi Laura, De Marchis Carlo, Della Rocca Grazia, Piccioni Maria Cancers (Basel) Systematic Review SIMPLE SUMMARY: Opioids are one of the therapeutic and palliative options for breast cancer, a tumor with a strong epidemiological impact. Studies have been extensively reported in the literature that show a connection between the administration of opioids and the recurrence of the disease, both during surgery and subsequently in the management of cancer pain. This argument, in consideration of the strong impact of this cancer, is of great interest. Therefore, we decided, through the study of the existing literature, to describe the state of the art on this topic, to outline the best therapeutic approach to be adopted in these delicate patients. ABSTRACT: Breast cancer has the greatest epidemiological impact in women. Opioids represent the most prescribed analgesics, both in surgical time and in immediate postoperative period, as well as in chronic pain management as palliative care. We made a systematic review analyzing the literature’s evidence about the safety of opioids in breast cancer treatment, focusing our attention on the link between opioid administration and increased relapses. The research has been conducted using the PubMed database. Preclinical studies, retrospective and prospective clinical studies, review articles and original articles were analyzed. In the literature, there are several preclinical in vitro and in vivo studies, suggesting a possible linkage between opioids administration and progression of cancer disease. Nevertheless, these results are not confirmed by clinical studies. The most recent evidence reassures the safety of opioids during surgical time as analgesic associated with anesthetics drugs, during postoperative period for optimal cancer-related pain management and in chronic use. Currently, there is controversial evidence suggesting a possible impact of opioids on breast cancer progression, but to date, it remains an unresolved issue. Although there is no conclusive evidence, we hope to arouse interest in the scientific community to always ensure the best standards of care for these patients. MDPI 2021-11-01 /pmc/articles/PMC8583615/ /pubmed/34771662 http://dx.doi.org/10.3390/cancers13215499 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Lucia, Merlino
Luca, Titi
Federica, Del Prete
Cecilia, Galli
Chiara, Mandosi
Laura, De Marchis
Carlo, Della Rocca
Grazia, Piccioni Maria
Opioids and Breast Cancer Recurrence: A Systematic Review
title Opioids and Breast Cancer Recurrence: A Systematic Review
title_full Opioids and Breast Cancer Recurrence: A Systematic Review
title_fullStr Opioids and Breast Cancer Recurrence: A Systematic Review
title_full_unstemmed Opioids and Breast Cancer Recurrence: A Systematic Review
title_short Opioids and Breast Cancer Recurrence: A Systematic Review
title_sort opioids and breast cancer recurrence: a systematic review
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8583615/
https://www.ncbi.nlm.nih.gov/pubmed/34771662
http://dx.doi.org/10.3390/cancers13215499
work_keys_str_mv AT luciamerlino opioidsandbreastcancerrecurrenceasystematicreview
AT lucatiti opioidsandbreastcancerrecurrenceasystematicreview
AT federicadelprete opioidsandbreastcancerrecurrenceasystematicreview
AT ceciliagalli opioidsandbreastcancerrecurrenceasystematicreview
AT chiaramandosi opioidsandbreastcancerrecurrenceasystematicreview
AT laurademarchis opioidsandbreastcancerrecurrenceasystematicreview
AT carlodellarocca opioidsandbreastcancerrecurrenceasystematicreview
AT graziapiccionimaria opioidsandbreastcancerrecurrenceasystematicreview